The relationship between the production of interleukin-6 and the proliferating cell nuclear Antigen (PCNA) expression in renal cell carcinoma

Acta Urologica Japonica

Volumn 44, Issue 4, 1998, Pages 233-238

  Ikeda, Ryosuke ^a   Moriyama, Manabu ^a   Nakade, Tadahiro ^a   Tsugawa, Ryuzo ^a   Suzuki, Koji ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Interleukin 6; PCNA; Renal cell carcinoma

Indexed keywords

CYCLINE; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0032038559     PISSN: 00181994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Muraguchi A. Hirano T, Tang B, et al.: The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167: 332-344, 1988
2. Yoshizaki K, Matsuda T, Nishimoto N, et al.: Pathogenic significance of interleukin 6 (BSF-2/IL-6) in Castlman's disease. Blood 74: 1360-1367, 1989
3. Kawano M, Hirano T, Matsuda T, et al.: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myeloma. Nature 332: 83-85, 1988
4. Miki S, Iwano M, Miki Y, et al.: Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250: 607-610, 1989
5. Tsukamoto T, Kumamoto Y, Miyao N, et al.: Interleukin-6 in renal cell carcinoma. J Urol 148: 1778-1782, 1992
6. Takenawa J, Kaneko Y, Fukumoto H, et al.: Enhanced expression of interleukin-6 in primary renal cell carcinoma. J Natl Cancer Inst 83: 1668-1672, 1991
7. Koo S, Armstrong C, Bochner B, et al.: Interleukin-6 and renal cell cancer: production, regulation and growth effects. Cancer Immunol Immunother 35: 97-105, 1992
8. Miyachi K, Fritzler MJ and Tan EM: Autoantibody to a nuclear antigen in proliferating cells. J Immunol 121: 2228-2234, 1978
9. Robbins BA, De la vega D, Ogata K, et al.: Immunohistochemical detection of proliferating cell nuclear andgen in solid human malignancies. Arch Pathol Lab Med 111: 841-845, 1987
10. Cronin KJ, Williams NN, Kerin MJ, et al.: Proliferating cell nuclear antigen : a new prognostic indicator in renal cell carcinoma. J Urol 152: 834-836, 1994
11. Delahunt B, Bethwaite PB, Nacey JN, et al.: Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nuclear organizer region numbers. J Pathol 170: 471-477, 1993
12. Larsson P, Roos G, Roger S, et al.: Proliferating cell nuclear antigen expression in renal cell carcinoma. Scand J Urol Nephrol 30: 445-450, 1996
13. Dosquet C, Schaetz A, Faucher C, et al.: Tumor necrosis factor-α, interleukin-1 β and interleukin-6 in patients with renal cell carcinoma. Eur J Cancer 30: 162-167, 1994
14. Fukatsu A, Matsuo S, Tamai H, et al.: Distribution of Interleukin-6 in normal and diseased human kidney. Lab Invest 65: 61-66, 1991